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CHAPTER 1 INTRODUCTION 
   Adenosine 3', 5'-monophosphate (cyclic AMP) was discovered by  Rall and Suthe-
rland in the course of their investigation on the role of epinephrine and glucagon in the 
breakdown of glycogen in liver  (Rall and Sutherland  1957  ;  Rall and Suterland  1958  ;
Sutherland and  Rall 1958). The substrate adenosine triphosphate (ATP) in the pres-
ence of  Mg' is enzymatically cleaved to form cyclic  AMP and pyrophosphate  (Rall 
and Sutherland 1962) (Fig. 1-1). The enzyme catalyzing this reaction, adenylate cy-
clase (Sutherland et al. 1962), was found in the plasma membrane of almost all species 
of animals (Sutherland et al. 1962). A phosphodiesterase which is found in both the 
soluble and particulate fractions of the cell, hydrolyzes cyclic AMP to  5'-rnonopho-
sphate (Sutherland and  Rall 1958). 
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           Fig. 1-1. The reactions catalyzed by adenylate cyclase and cyclic AMP
                phosphodiesterase.  A.0  :  Adenylate cyclase.  P.D: CyclicAMP
                 phosphodiesterase. 
   Cyclic AMP is widely distributed in nature and has been detected in several 
bacteria  (Hirata and Hayaishi  1965  ; Makmann and Sutherland  1965  ; Brana  1969  ; 
Tao and Lipmann 1969), slice mold (Konijin et al . 1967), higher plants (Pollard  1970  ;
Duffus and  Duffus  1969  ; Azhar and Hrishnamurti 1971), and almost  all animal tissues 
so far studied (Ebadi et al. 1971). Interaction of a number of polypeptide hormones 
and biogenic amines with their respective target tissues leads to an enhanced produc-
tion of cyclic AMP in these cells. The increase in the level of cyclic AMP precedes to 
all metabolic and physiological response elicited by hormones. These observations 
led Sutherland et al. to propose cyclic AMP as a second messenger in hormone action 
(Sutherland et al.  1965  ; Robison et al.  1967  ; Sutherland et al. 1968). Cyclic AMP 
alters metabolic and physiological responses either directly or indirectly by releasing 
certain hormones  (Rasmussen and Tenenhouse 1968) which in turn may act via cyclic 
AMP on their target tissues. 
   Various hormones are known to be capable of stimulating adenylate cyclase. It 
has been reported that the following criteria shoud be satisfied in order to justify a 
claim that a given hormone produce a given effect as a result of this action (Robison 
et al. 1971). 
(1) The hormone should be capable of stimulating adenylate cyclase in broken cell 
   preparations from the approciate cells, while hormones which do not produce the 
   response should not stimulate adenylate cyclase. 
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(2) The hormone should be capable of increasing the intracellular level of cyclic 
   AMP in target cells, while inactive hormones should not increase cyclic AMP 
   levels. It should be demonstrated that the effect on the level of cyclic AMP 
   occurs at dose levels of the hormone which are at lease as small as the smallest 
   levels which are capable of producing a physiological response. The increase in 
   the level of cyclic AMP should precede or at least not follow the physiological 
    response. 
(3) It should be possible to potentiate the hormone (i.e., increase the magnitude of the 
   physiological response) by administering the hormone together with  theophylline 
   or other phosphodiesterase inhibitors. The hormone and the phosphodiesterase 
   inhibitor should act synergistically. 
(4) It should be possible to mimic the physiological effect of the hormone by the 
   addition of exogenous cyclic AMP. 
   In brain, the amines such as epinephrine, norepinephrine, histamine, and serotonin 
stimulate cyclic AMP formation (Sattin and  Rall 1967, 1970 ; Kakiuchi and Rall 1968a, 
 b  ; Schimizu et al. 1969, 1970a, b, c). Information regarding the hormonal regulation 
of cyclic AMP formation in brain is lacking due to two  difficulties  : (a) within a few 
seconds after death the level of cyclic AMP in brain increases several-fold, unless 
special care is taken to freeze the tissue quickly (Kakiuchi and Rall  1968a  ; Paul et al. 
1970). (b) The enzyme in broken cell preparations loses its response to activation by 
hormones. Decrease in hormone response in broken cell preparations is observed in 
some tissues (Forn et al. 1970) but not in others (Moskowitz et al. 1970). For these 
reasons, brain slices have been used for studies of cerebral adenylate cyclase in vitro. 
In such experiments, slices are preincubated with  '4C- or  3H-adenine, and the  forma-
tion of cyclic AMP is monitored from the prelabeled pool of ATP. During typical 
experiments, in which rat cerebral cortex slices preincubated with adenine are incu-
bated in the presence of norepinephrine, 5-6% of labeled ATP is converted to cyclic 
AMP in the first minutes. In terms of percentage of total ATP converted to cyclic 
AMP, the conversion is about  0.5%. These observations suggest that there are sev-
eral pools of ATP in slices, and at least one pool is preferentially labeled when incu-
bated with adenine. Possibly ATP in this  pool is easily accessible to adenylate cy-
clase, which is stimulated by norepinephrine (Krishna et al. 1970). 
   As mentioned above, in contrast to most tissues, broken cell preparations of ade-
nylate  cyclase from brain tissue do not respond to neurohormones with increase in the 
rate of synthesis of cyclic AMP (William et al. 1969 ;  Rall and Sattin 1970 ; McCune et 
al. 1971).  However, brain has the highest capacity for synthesizing cyclic AMP 
(Sutherland et al. 1962) as well as the highest levels of cyclic nucleotide phosphodie-
sterase (Butcher and Sutherland 1962). For these reasons, many workers have in-
vestigated the role of cyclic AMP in the central nervous system. 
   In light of observations (Bitensky et al.  1968  ; Oye and Sutherland 1966) that 
similar loss of hormone sensitivity was seen in other tissue homogenates, it seems 
likely that some essential substances for the stimulation of the  enzyme by such  neu-
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rotransmitters are removed from the membrane during homogenization and fraction-
ation of the  tissues. There is little data, however, on these substances and whether or 
not they have any influence on the adenylate cyclase. In the experiments published so 
far the particulate fraction was suspended in buffer solution without the presence of 
soluble supernatant fraction. 
   In the present thesis, the effect of the 105,000 x g supernatant fraction (super-
natant) and the effects of combination of the supernatant and various agents such as 
neurotransmitters and sodium fluoride, which is the well-known potent activator of 
adenylate cyclase, on the adenylate cyclase of rat cerebral cortex were investigated 
(Izumi and Ozawa  1975  ; Izumi et al.  1975a  ; Izumi and Ozawa 1976  ; Izumi et al. 
1976e). 
CHAPTER 2. ASSAY OF ADENYLATE CYCLASE 
   Early work on adenylase cyclaserelied on biological assays of cyclic AMP  (Rall 
and Sutherland 1958, 1962). These techniques were tedious and usually involved 
extensive purification of cyclic AMP samples since they involved multicomponent 
enzyme system whose activity could be influenced by a number of adenine nucleotides 
and certain hexoses. With the availability of radioactively labeled ATP and the 
advent of quick, simple methods for the purification of cyclic AMP, investigators were 
provided with a direct radiometric assay procedure for adenylate cyclase activity in 
broken cell preparations (Rabinowitz et al.  1965  ;  Street() and Reddy 1967 ; Krishna et 
al.  1968  ; Barr and Hechter 1969). 
   The most widely used method for the isolation of cyclic  AMP from adenylate 
cyclase reaction mixtures is that of Krishna et al. (1968). The procedure involves 
chromatography of the samples on a column of Dowex 50 followed by the precipitation 
of containing nucleotides with  ZnSO4 and Ba(OH)2. 
   In the present experiments, a modifiedmethod of Krishna et al. (1968) was utilized 
and  3H-ATP was used as a substrate of the reaction system in the assay of adenylate 
cyclase activity. In case of low purity of a commercial 3H- ATP, it is sometimes 
necessary to purify it by column chromatography on Dowex  50W-H-, or by a thin 
layer chromatography on silica gel. Then, the labeled ATP was mixed with un-
labeled material prior to the assay to give the required specific activity. 
   The incubation medium for the assay of adenylate cyclase activity  contains  :
 Tris-HCI (tris (hydroxymethyl)aminoethane HC1) buffer,  pH 7.4 (4 x  10-2M)  ;  MgSO4 
(3.3 x  10-3M)  ; NaF  (10-2M)  ; caffeine (6 x  10-3M)  ; ATP  (10-3M, 10  AL  Ci) and enzymes 
 (0.1-1.0 mg of tissue) in final volume of 0.6 ml. Test tubes (12 x 105 mm) containing all 
the ingredients for the assay of adenylate cyclase activity were preincubated for 5  min 
at  30°C prior to addition of substrate (ATP) which started the reaction. Incubations 
were carried out for 15  min at  30°C and terminated by the immersion of the test tubes 
in a boiling water bath for 2  min. As illustrated in Table 2-1, after addition of 0.1 ml 
of  ` 4C-cyclic AMP (about 5,000 dpm) as an internal standard for calculation of  con-
                                       - 3 ---
                                      Table 2-1. 
                          _ --- 
                Purification of Cyclic AMP 
                 Incubation of the reactionmedium at  30C for 15  min 
 Boiling for 2  min. then cooling 
                 Addition of internal standard 
 ("C  Cyclic AMP. 5.000  dprn) 
                Removal of  ATI' by the addition of ZnSO, &  Ha(OFI), 
 (t•ice) 
                               Centrifugation(1,000Ng for 20  min) 
 ITT (Discard)  
I  on exchange  column chromatography with 
                                     Dowex  SOW  X--1(0.3 x 8cm)
                  Fractionation  (HA 
                  Liquid scintillation  spectrometory 
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          Fig. 2 1.  Adenylate  cyclase activity of rat brain  synaptosomes as a func-
               tion of time. Each sample contained synaptosomes (0.2 mg of  pro-
               tein) as enzyme sources. Incubation was conducted for various
               times at  30-C. 
version of  3H-ATP to 3H-cyclic AMP , 0.1 ml of each of  ZnSO4 (0.17 M) and Ba(OH)2 
(0.15 M) solutions was added to each tube. The supernatant solution was transferred 
to another tube by decantation, and then the Ba-Zn precipitation was performed for a 
second time. The mixture was agitated and centrifuged at 1,000 x g for 10  min. The 
resulting supernatant was applied to a column of Dowex 50W-X4 in the hydrogen 
from (0.3 x 8 cm) and then cyclic AMP was eluted with water . Every 1 ml of the 
eluate was collected and transferred to a counting vial with 10 ml of scintillating fluid 
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           Fig. 2-2. Adenylate cyclase activity of synaptosomal nd crudemito-
                chondria] fractions from rat brain as a function of enzyme concen-
                  tration. 
which contained 4 g PPO, 100 mg dimethyl  POPOP and 500 g triton X-100 in  1 liter of 
toluene. The radioactivity was determined by a liquid scintillation spectrometer 
(Packard-Carb Model 3380) and corrected for quenching using an external standardi-
zation system. The recovery of cyclic AMP was 75-80%. 
   Figure 2-1 shows the assay of adenylate cyclase of rat brain synaptosomes using 
 3H-ATP as substrate as a function of time. The rate of formation of cyclic AMP 
was linear with time up to 30  min. Figure 2-2 shows the effects of varying protein 
concentrations upon the rate of cyclic AMP formation. In both enzyme preprations, 
the rate of cyclic AMP  acumulation was proportional to protein concentration used. 
   Based on these experimental data, most experiments were carried out with a 15 
 min incubation time and with a protein concentration of 200  p g in 0.6 ml of incubation 
 medium. 
CHAPTER 3. EFFECTS OF THE SUPERNATANT ON THE ADENYLATN CYCLASE OF RAT 
         CEREBRAL CORTEX 
3-1. Effect of Supernatant on Subcellular Fractions 
   The effects of the supernatant on adenylate cyclase of subcellular fractions of rat 
cerebral cortex were investigated. The data in Table 3-1 show that the enzyme 
activity in crude mitochondrial fraction was significantly stimulated by the addition of 
the supernatant. Since the crude  mitochondrial fraction contains the free  mitochon-
dria and a variety of isolated nerve endings (Whittaker 1959), this fraction was further 
fractionated into three fractions, i.e., myeline, synaptosomes and mitochondria by a 
sucrose density gradient ultracentrifugation methed (Whittaker 1959) in order to 
obtain more information about the effect of the supernatant on adenylate cyclase, and 
each enzyme activity was then determined in the absence and in the presence of the 
supernatant. As shown in Table 3-2, three particulate fractions showed similar en-
zyme activities in the absence of the supernatant, while upon addition of the super-
natant the enzyme activity in synaptosmes was activated more markedly than those in 
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            Table 3  -1. Effect of supernatant on adenylate cyclase activity in 
 subcellular fractions from rat cerebral cortex 
                                     Adenylate Cyclase Activity
                                (pmoles cyclic  AMP/min per mg protein) 
       FractionsWithout  With 
 supernatant supernatant 
 1,000 xg supernatant 
             (Whole homogenate)71.7 1 . 3 
 10,000 xg sediment 
             (Crude mitochondria)61.8  ± 4.0  150.0 ±  4.6 
 105,000  xg  sediment 
           (Microsome)92.0 ±  22.4 102.0  ± 5.1 
 105,000 xg supernatant 0 0 
             The subcellular fraction of rat cerebral cortex was obtained as de-
            scribed in Methods. The supernatant obtained after centrifugation at
 105,000  xg, equivalent to 180  jig of  protein, was added to each of the 
            other fractions. Each value was the mean of 3 determinations of one
              fractionation. 
               Table 3-2. Effect of supernatant on adenylate cyclase activ-
                    ity in submitochondrial fractions 
 
- 
.   
                                  Adenylate cyclase activity 
                            (pmoles cyclic  AMP/min per mg protein)
                     Without With
                Fractions 
                                 supernatant supernatant 
              Mitochondria  21.3 ±  3  .  4 49.3± 2.8 
 Synaptosomes 38.8 ± 5.6  117  . 7±  1  .  3 
           Myelin 34.5 ± 12.1  63.1 ±  10.3 
 Fractions from rat homogenates  (1,000 xg—  10,00(1 xg) was 
 subfractionated bya discontinuous sucrose gradient centrifu-
               gation. The supernatant obtained as described in Methods,
              equivalent to  181)  jig of  protein. was added to each incubation 
 medium. Each value was the mean of 3 determination f one 
                 fractionation. 
the other two  fractions. Fig. 3-1 shows that the adenylate cyclase activity in the 
crude  mitochondria' fraction resides largely in the synaptosomal fraction (about 61%). 
   In order to determine whether or not the synaptosomal fraction described above is 
rich in nerve ending and other synaptic components, the morphologic study was 
undertaken. Electron micrograph (Fig. 3-2) of the synaptosomal fraction shows that 
there are numenous nerve endings and tiny axon terminals filled with typical synaptic 
vesicles. This fraction contains very little of  my-eline and mitochondria. 
3-2.  Discussion 
   It is  well established that  adenylate  cyclase is stimulated by various neurotrans-
mitters such as norepinephrine, 5-hydroxytryptamine (serotonin) and histamine in 
brain slice (Sattin and Rail 1967, 1970  ; Kakiuchi and Rail 1968a,  b  ; Schimizu et al. 
1969, 1970a, b,  c  ;  Chasin et al 1971a, b, 1973) and by direct administration of  mono-
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 Fig. 3 2. Electron micrograph of a synaptosomal fraction.  Numerous 
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amine into the central system (Chou et al. 1971). However, failure to obtain stimula-
tion of brain  adenylate cyclase by hormone and putative neurotransmitters in cell-free 
 system has been reported  (William et  al.  1969  ;  Rall and Sattin  1970  ; McCune et al. 
1971). These data suggest that there are some other compounds, as yet unidentified, 
which may be the physiological stimulants for brain adenylate cyclase. 
   Previously, in the process of studying the distributions of adeylate cyclase of both 
bovine pineal gland and rat cerebellum, Weiss and Costa (1968) have found that in con-
trast to bovine  pineal gland, fractionation of the cerebellum decreases the specific acti-
vity of the enzyme. Therefore, they have investigated the effect of the soluble superna-
tant material on the  adenylate cyclase activity of subcellular fractions of rat cerebel-
lar homogenates. It was found that the soluble supernatant materials, which itself 
had no adenylate cyclase activity, significantly enhanced the enzyme activity of the 
 11,500 x g (crude  mitochondria]) fraction but not that of other fractions. From these 
results, they suggested that the decrease in specific activity of subcellular fractions of 
cerebellar homogenates might be ascribable to a removal of some essential  require; 
ment or activator of the enzyme. Accordingly, the effectts of the 105,000 x g super-
natant (supernatant) on the adenylate cyclase activity of subcellular fractions of rat 
brain cerebral corebral cortex were investigated in order to gain more information 
about the involvement of the stimulatory substance(s) in the supernatant in other 
tissues such as rat cerebral cortex. As seen in Table  3-1, the enzyme activity of the 
crude  mitochondrial fraction was markedly stimulated by the  addition of the super-
natant, which is in good agreement with those previously reported by Weiss and Costa 
(1968) concerning the supernatant stimulation of adenylate cyclase of mitochondrial 
fraction from rat cerebellum mentioned above. In light of the observations in Tables 
3-2 and Fig.  3-1, this increase of cyclic AMP accumulation may be due to largely to 
the stimulation of the synaptosomal adenylate cyclase by the supernatant. These 
findings suggest that adenylate cyclase of synaptosomes may be different  from the 
enzyme present in other particulate fractions of rat cerebral cortex, and that the 
adenylate cyclase of synaptosomal membranes may be regulated by endogenous 
substances in the rat brain. For these reasons, the properties of synaptosomal ade-
nylate cyclase and the characterization of the stimulatory substance(s) in the super-
natant were investigated, and the results are described in the following chapter. 
CHAPTER 4. CHARACTERIZATION OF STIMULATORY  SUBSTANCE  (s) IN THE SUPER-
          NATANT 
 4-1. Effect of Concentration of the Supernatant 
   The relationship between the degree of the stimulation and the concentration of 
the supernatant is depicted in Fig. 4-1. As the concentration of the supernatant in-
creased, the accumulation of cyclic AMP progressively increased, reaching a plateau 
at a concentration of about  200  pg protein. In the assay of the stimulatory activity 
described in the present studies, preliminary experiments were usually carried out to 
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         Fig.  4-1. Effects of supernatant concentration on adenvlate cyclase ac-
               tivity in  synaptosomes from rat cerebral cortex . The supernatant 
              was obtained as described in  Methods. The amount of supernatant 
              varied from 0 to 250  mg of protein. 
                      Table 4-1. Effect of Dialysis of Supernatant 
  - -  _   - - -- 
             AdditionsAdenvlate cyclase activity                                        (pmoles cyclic AMP/min. mg protein) 
 None-control 39.3 -± 10.9 
   Supernatant  126.3+ 8.7 
         (dialyzed for 6 hr)  61.5±11.4
         (dialyzed for 12 hr) 40.5± 3.8 
         The supernatant (130  pg protein) was obtained as describedin  Nlethods and 
       then dialyzed for 6 hours (2 x 500 volumes) and 24 hours  14  x 500 volumes) versus 
        30  ml\I  Tris--buffer (pH  7.41. Data were averages  ± S.D. of 3 separate analyses. 
determine the amount of protein of the supernatant so that linear part of the curve 
was used. 
4-2. Effect of Dialysis 
   The effect of dialysis of the supernatant has been examined (Table  4-1). The 
supernatant was dialyzed for 6 hours at  4°C (2 x 500 volumes). Dialysis of the super-
natant caused a marked loss of the stimulatory activity. Larger dialysis (24 hours, 
4 x 500 volumes) of the supernatant resulted in a complete loss of the stimulatory 
activity. 
4-3. Chromatography on Sephadex G-25 Superfine 
   The stimulatory substance in the supernatant was  purified using chromatography 
on Sephadex G-25 superfine. Figure 4-2 depicts the elution profile of the lyophilized 
supernatant from the column. As seen in Fig. 4-2, the peak stimulated activity was 
eluted at 53 ml. Calibration of this column with glucagon  (M.W. 3,350) and vitamin 
 Bi2 (M.W. 1,350) as markers indicated that this elution volume corresponded to a 
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         Fig. 4-2. Chromatography of  adenylate cyclase stimulatory substance(s) 
               on Sephadex G-25 superfine. Rat brain cerebral cortex was ho-
             mogenized in  five volumes of ice cold 50  m11,1  Tris-HCl buffer (pH
              7.4). The homogenates were  centrifuged  ; 1,000 x g for 20  min,
 10,000 x g for 20  min and 105,000 x g for 60  min. The resulting su-
             pernatant was lyopyilized and then applied to a column of Sephadex 
             G-25 superfine (1.5 x 43 cm) equilibrated  previously in the homoge-
              nization buffer. The column was eluted at  4=C with the same buffer 
              in 2.5 ml fractions at a flow rate of 10 ml per hour. An aliquot (0.1
             ml) of each fraction was assayed for its adility to activate the
               synaptosomal adenylate activity. The void volume of the column
              was 23 ml and the peak stimulated activity was eluted at 53 ml.
                        Table 4-2. Effect of Heat Treatment 
_  _  • - _ - _ _ _ 
         AdditionsCyclic AMP formed  (pmoles/mg of  pr tein; min) 
  None  50.6± 3.3 
   Supernatant  105.1±0.3 
     Boiled supernatant 384.1 ±30.9 
         The native and boiled supernatants were obtained as described in Methods. 
       The amounts of the natvie and boiled supernatants were 150  pg and 130  /2 g of 
        protein, respectively. Data were averages ± S.D. of 3 separate analyses. 
molecular weight of less than 1,300. 
4-4. Effect of Heat Treatment 
 When the supernatant was heated in a boiling water bath for 5  min and then, after 
10-20  min at 0°C, added to the reaction mixture, the rate of cyclic AMP accumulation 
was much higher than by the native supernatant (Table 4-2). This finding indicates 
that the stimulatory substance(s) was heat-stable. The difference of cyclic AMP 
accumulation between the native supernatant and the boiled supernatant seems to be 
ascribable to the presence of cyclic AMP phosphodiesterase which involved in the 
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Fig. 4-4. Chromatography of  adenylate cyclase  stimulatory substance(s) 
     on Sephadex G-25 superfine. The boiled supernatant was prepared 
     by heating the 105,000 x g supernatant from rat brain shown in Fig. 
     4-2 in a boiling water bath and then centrifuged at  10,000 x g for 10 
 min to remove denatured proteins. This supernatant was lyophi-
     lized and then applied to a column of Sephadex G-25 superfine (1.5 
     43 cm) equilibrated previously in the homogenization buffer. The 
     column was eluted at  4'C  with same buffer in 2.5 ml fractions at a 
     flow rate of 10 ml per hour. An aliquot (100  j.t I) of each fraction
     was assayed for its ability to activate the  synaptosomal  adenylate 
     cyclase activity. The void volume of the column was 23 ml and the 
     peak stimulated activity was eluted at 53 ml. 
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                            Table 1 3. Separation of the boiled supernatant by  ul-
                                 trafiltration  (G-01T) 
                      AdditionsCyclic AMP formed  (pmoles/mg of  protein/min) 
             None 63.5 ±  1.8 
                           Boiled supernatant 322.3 ± 2.6
                          Filtrate of  G-01T  67.6 ± 7.2
                              The boiled supernatant obtained as describedin Meth-
                            ods, equivalent to 350  mg of protein, was added to each
                             incubation medium. The boiled supernatant was filtrated
                           with Ulvac ultrafiltration cell equipped with a  G-01T
                            membrane, and then an aliquot of the filtrate was assayed 
                           for its ability to stimulate synaptosomal adenylatecycla-
                               se. Data were averages  -1- S.D. of 3 separate analyses.
         hydrolysis of cyclic AMP in the native supernatant. 
 When the concentration of the boiled supernatant increased as well as shown in 
         Fig. 4-1, the extent of cyclic AMP accumulation was progressively greater (Fig.  4-3). 
 When the boiled supernatant was fractionated by column  chromatography (Sephadex 
         G-25 superfine), similar peaks of stimulatory substance(s) were observed (Fig. 4-4). 
         4-5.  Ultrafiltaltion 
            To determine more precise molecular weight of the stimulatory substance(s), 
         ultrafiltration method (Blatt 1971) was used (Table 4-3). The  'boiled supernatant was 
         filtrated with a Ulvac ultrafiltration cell equipped with a  G-01T membrane, and then 
         an aliquot (100  g  1) of the filtrate was assayed for its ability to stimulate the adenylate 
         cyclase activity. The results are shown in Table 4-3. This filtrate did not stimulate 
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                     Fig. 4-  5. Effects of  Mg— concentration adenylate cyclase activity in 
 synaptosomes in the absence (open symbols) and in the presence 
                         (closed symbols) of the boiled supernatant (0.3 mg of protein).
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the enzymic activity at all, indicating that the stimulatory substance(s) has a molecu-
lar weight of more than 1,000. From the above results (Figs. 4-2, 4) and the present 
data (Table 4-3), the stimulatory substance(s) was estimated to have a molecular 
weight in the range of 1,000-1,300. 
4-6. Effect of  Mg" 
   The effect of  Mg' concentration on the adenylate cyclase activity in synapto-
somes in the absence and in the presence of the boiled supernatant is given in Fig. 4-5. 
When the concentration of ATP was fixed at 1 mM, the enzymic activity was not 
detected in the absence of  Mg" with and without the presence of the boiled super-
natant whereas an increase in  Mg' concentration caused a progressive increase in the 
activity of adenylate cyclase with and without the presence of the boiled supernatant. 
4-7. Effect of Substrate (ATP) 
   Assays of adenylate cyclase in synaptosomes were conducted in various ATP 
concentrations (Fig. 4-6). The calculation on the basis of the data obtained in the 
present studies revealed that Km values were 0.40 x  10' and 0.41 x  10-3M in the ab-
sence and in the presence of the boiled supernatant, respectively, and Vmax values 
were 80 pmoles/min per mg protein and 400  pmoles/min per mg protein in the absence 
and in the presence of the boiled supernatant, respectively. Thus the boiled super-
natant caused a five-fold increase of adenylate cyclase activity without significant. 
influence on the Km values. 
4-8. Discussion 
   From the results in this chapter, it was found that the stimulatory substance(s) in 
the supernatant was heat-stable, dialyzable, and had a molecular weight of about 
1,200. However, at this stage, the detail nature of this substance(s) has not yet been 
clarified. 
                              400 
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 Fig. 4-6. Mechanism of the stimulatory effect of adenylate cyclase by the 
               boiled supernatant (0.3 mg of protein). The effect of the boiled 
               supernatant was studied by the double reciprocal plot  (inset). 
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   As can  be seen from  Fig. 4-5, adenylate cyclase in synaptosomes requires  Mg— 
for its activity and for its stimulation by the boiled supernatant. The basal activity of 
the enzyme was increased and then reached a plateau at  Mg" concentration of 4  ml 
and in the presence of the boiled supernatant the enzymic activity peaked at the same 
 Mg' concentration. 
   It is concluded that while the  stimulatory effect of the boiled supernatant is due to 
an increase in Vmax value, there is no significant effect of the apparent affinity for 
substrate (ATP)  (Fig.  4-6). The present results suggest that this stimulation is 
similar kinetically to the stimulations of fluoride (Bar et al. 1969) and hormone 
(Drummond et al. 1971). Although it was found the optimun concentration of ATP to 
be 0.8 mM, the significance of this value is difficult to asses since the isolated syn-
aptosomes contain other enzymes which act on ATP, ADP, and AMP. These en-
zymes are ATPase,  myokinase, ATP pyrophosphohydrolase and 5'-nucleotidase. 
Hence the actual concentration of ATP added to the synaptosomes is very rapidly 
lowered by the active ATPase and partially regenerated by myokinase. Birnbaumer 
and Rodbell (1969) attempted to circumvent this problem by adding ATP generating 
enzymes. However, Dunnick et al. (1972) have recently reported that the effect of a 
ATP regenerating system on adenylate cyclase is negligible. Accordingly, unless the 
ATP levels are actually measured at different time intervals, the true concentration of 
ATP remains unknown. 
   In many tissues the intracellular level of cyclic AMP is an important factor in the 
regulation of cell metabolism.  In the absence of an external stimulus the concentra-
tion of bound and free cyclic AMP in various tissues are of the order of  10-7-10-8M. 
This concentration is 1,000-10,000 times lower than that of ATP or 5'-AMP. The 
concentration of cyclic AMP in the cell is a function of the rates of its synthesis and 
degradation, which at any given times are determined by the relative activities of 
                   (A) 
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          Fig.  4  7. (A) Rate of cyclic AMP hydrolysis  in supernatant of the rat 
                 cerebral cortex.  —0--  :  93  ,ug protein concentration of the  super-
                natant.  —1  :  46  p  g protein concentration of the supernatant.
 (B(  Double-reciprocal plot of the hydrolysis of cyclic AMP by the 
 supernatant from rat cerebral cortex. Substrate concentrations 
              ranged from 33.75  u  NI to 360  u M for cyclic AMP. 
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adenylate cyclase and cyclic AMP phosphodiesterase. These activities are undoubtly 
influenced by a number of factors in addition to hormones, and very little is understood 
about their modes of action. Although cyclic AMP phosphodiesterase in the super-
natant is several times higher than that of adenylate cyclase in synaptosomes as 
shown in Fig.  4-7 (A), addition of the supernatant to the adenylate cyclase assay sys-
tem does not decrease the cyclic AMP levels, but increase it. This may occur because 
of sequestration of cyclic AMP in bound form with the receptor protein or by  com-
partmentalization of cyclic AMP in a part of the cell inaccessible to cyclic AMP 
phosphodiesterase, and high Km value of cyclic AMP phosphodiesterase in the super-
natant  (130  AIM) (Fig. 4-7B). 
CHAPTER 5. SITE OF ACTION OF THE  STIMULATORY  SUBSTANCE(s) 
 5-I. Effects of  the Native and Boiled Supernatants on Brain  ATPase 
   In order to determine whether or not the boiled supernatant induced enhancement 
of cyclic AMP accumulation was due to increased availability of substrate (ATP) for 
adenylate  cyclase, the effects of the native and the boiled supernatants on the brain 
ATPase activity in synaptosomes were investigated, and the results are shown in 
Table  5-1. As can be seen, the native and boiled supernatants inhibited ATPase 
activity by about 20%. 
5-2. Effects of the Boiled Supernatant on Cyclic AMP Phosphodiesterase 
   To determine whether or not the boiled supernatant-induced stimulation of cyclic 
             Table 5-1. Effects of the basal and boiled  supernatants on  synapto-
                 somal ATPase activity 
 ---   
        AdditionsATPase activity  LumolesPO4/mg per  min) 
 None 5.21 ±  0.06 
              Native supernatant  (366  g  g protein) 4.28  ± 0.04* 
              Boiled supernatant  (300  u  g protein) 4.07  ± 0.05* 
             * Significantly different from control  (p<0.01) 
               Data are averages  ±S.D. of 3 separate analyses.
             Table 5-2. Effect of the boiled supernatant on cyclic AMP phos-
                  phodiesterase activity 
                                               Preparations AdditionCyclic AMP  hydrolyzed  (nmoIes/15  min) 
           Synaptosomes  (100mg protein) 40.4 7.8
 Boiled supernatant 65.1  ± 1.  1* 
 Synaptosomes (200  ,u  g protein) 66.3  3.5 
 + Boiled  supernatant  102.5  ± 1.3*  
*  p<0 .001 compared with each control. 
              The boiled  supbrnatant obtained as described in Methods, equiva-
             lent 300  fig of protein,  --as added to each incubation medium. Data
              are averages  ±S.D. of  „ separate analyses. 
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AMP accumulation occurred at the cyclic AMP phosphodiesterase step, the effects of 
the boiled supernatant on cyclic AMP phosphodiesterase activity in synaptosomes 
were investigated and the results are shown in Table 5-2. As can be seen, the syn-
aptosomal cyclic AMP phosphodiesterase activity was also stimulated by the additi-
tion of the boiled supernatant about 1.5 fold, indicating that the stimulatory effect of 
the boiled supernatant on cyclic AMP accumulation was not the result of the inhibition 
of cyclic AMP phosphodiesterase activity. 
5- 3.  EtIcci of Sodium  fluoride (NaF) on Adenylate  Cyclase and  ATPase 
   In order to compare the concentration-response relationships between the inhibi-
tion of ATPase by sodium fluoride and the accumulation of cyclic AMP, the following 
experiments were carried out. As can be seen from Fig.  5-1, as the concentration of 
sodium fluoride increased, the extent of the inhibition of synaptosomal ATPase  ac-
tivity was proportionally greater, and, on the other hand, activation of synaptosomal 
adenylate cyclase by sodium fluoride was maximal at a concentration of about 5 mM 
 higher concentrations of sodium fluoride reduced enzymic stimulation, indicating 
that there was no correlation between these two effects. 
5-4. Disussion 
   As shown in chapter 2, 3, the native and boiled supernatants increased the accu-
mulation of cyclic AMP about several fold when added to the adenylate cyclase assay 
system in  synaptosomes from rat cerebral cortex. Adenylate  cyclase from most tis-
sues is not readily purified, primarily because it is membrane-bound and is relatively 
unstable. In the present studies, synaptosomes were utilized as an enzyme prepara-
tion. This preparation contains amount of ATPase and Cyclic AMP phosphodiester-
ase activities and whose presence therefore must be considered. Although other pos-
sibilities cannot be excluded completely at this stage, the ability of the boiled super-
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          Fig. 5-1. Effects of various concentrations of sodium fluoride on ade-
              nylate cyclase activity (closed symbols) and ATPase activity (open
                symbols) in synaptosomes. 
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natant to stimulate cyclic AMP accumulation in synaptosomes may be due to the 
following three  reasons  : 1) direct stimulation of synaptosomal adenylate cyclase, 2) 
increase of the available substrate (ATP) by inhibition of the  synaptosomal ATPase 
activity and 3) inhibition of synaptosomal cyclic AMP phosphodiesterase activity. As 
can be seen from Fig.  5-1, a study of the concentration response relationship between 
the inhibition of ATPase by sodium fluoride and stimulation of the accumulation of 
cyclic AMP revealed no correlation between the two effects, indicating that ATPase 
inhibition and cyclic AMP accumulation are not causally related. This suggests that 
the slight inhibition of ATPase activity by the boiled supernatant (Table  5-  1) might 
not induce a marked increase of cyclic AMP accumulation. Schaefer et al. (1972, 
 1973,  1974,  1975) have previously reported the presence of the soluble inhibitory sub-
stance(s) on ATPase of rat brain. On the other hand, synaptosomal cyclic AMP 
phosphodiesterse was not inhibited but rather stimulated by the addition of the boiled 
supernatant as seen in Table 5-2. This stimulatory effect of the boiled supernatant on 
cyclic AMP phosphodiesterase was further investigated in the following chapter 7. 
The results shown in Table 5-2 indicate that the  stimulatory effect of the boiled 
supernatant on cyclic AMP accumulation is apparently unrelated to the cyclic AMP 
phosphodiesterase activity. Although other possibilties cannot be excluded com-
pletely at this stage, it is conceivable from the above results that the mechanism 
responsible for the stimulation of accumulation of cyclic AMP by the stimulatory 
substance(s) in the supernatant might consist of an activation of  adenylate cyclase. 
 However, proof for the mechanism of this stimulatory effect on cyclic  AMP formation 
in synaptosomes must await purifications of both enzyme  (adenylate cyclase) and the 
stimulatory substance(s) in the supernatant. 
CHAPTER 6. EFFECTS OF VARIOUS AGENTS ON SYNAPTOSOMAL ADENYLATE  Cy-
            CLASE 
6-1. Effect of Norepinephrine 
   As noted in the introduction, since it has been reported that the adenylate cyclase 
activity of brain tissue homogenates is not stimululated by catecholamine, the effect of 
         Table 6-1. The effects of norepinephrine and supernatant on adenylate 
              cyclase activity in synaptosomes 
 Additions Adenylate cyclase activity  (
pmoles cyclic  AMP/min per mg protein) 
   None 38.1 ± 2.4 
    Supernatant 104.7 ± 3.3 
       Norepinephrine (100  ,u M)  33.4 ± 4.7 
 Supernatant  + N  orepinephrine  54.7 ±  5.0 
          The supernatant obtained as described in Methods, equivalent to 140  it  g of 
         protein, was added to each incubation medium. Norepinephrine was added 
         at  100  ke  M. Data were averages  ±S.D. of 3 separate analyses. 
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          Fig.  6--1. Effects of the supernatanton the synaptosomal  denylate 
               cyclase  activity in the presence of various concentrations of sodium 
              fluoride (NaF). Sodium fluoride was added to the assay mixytureat 
               the concentrations indicated. The supernatant, equivalent 180  gg
              of protein, was obtained as described in Methods and was added to 
               incubation medium. 
norepinephrine on synaptosomal adenylate cyclase activity has been investigated in 
the absence and in the presence of the supernatant. As seen in Table  6-1, in contrast 
to the stimulatory effect of the supernatant, norepinephrine (100  gM) did not influence 
the basal enzyme activity significantly. On the other hand, the stimulatory effect of 
the supernatant was markedly reduced by the addition of norepinephrine. 
6-2. Effect of Sodium Fluoride 
   Sodium fluoride is a well-known potent activator of adenylate cyclase in various 
tissue homogenates (Perkin and Moore 1971 ; Barr and Hechter  1969  ; Drummond et 
al.  1971 ; Weiss  1969  ; Menson et al 1973). In order to determine whether the sites of 
actions of the stimulatory substance(s) in the supernatant and sodium fluoride on the 
cyclic AMP accumulation are the same or not, the effect of the supernatant on the 
adenylate cyclase activity in the absence and in the presence of sodium fluoride was 
investigated. As seen in  Fig.  6-1, the stimulatory substance(s) induced a further in-
crease in the rate of the formation of cyclic AMP in the presence of sodium fluoride, 
indicating that the stimulatory snbstance(s) and sodium fluoride act at distinctly 
different sites in the adenylate cyclase system of rat brain synaptosomes. 
6-3. Role of Sulfhydryl Groups 
   The effects of p chloromercuribenzoate (p-CMB), which reacts with sulfhydryl 
groups, in various concentrations on the  synaptosomal adenylate cyclase in the 
absence and in the presence of the boiled supernatant are given in Fig. 6-2. The basal 
enzyme activity was not affected by the addition of p-CMB at  10-8M concentration 
but was inhibited  by the addition of more than  10-5M p-CMB. On the other hand, 
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          Fig. 6-2. Dose response curve showing the effectof p-CMB on the cyclic 
               AMP formation in synaptosomes in the absence (open symbols) and
               in the presence (closed symbols) of the boiled supernatant (0.35 mgof
                protein). 
    Table 6-2. The effects of  sulfhydryl reagents on the formation of cyclic AMP 
 A*  B5Cyclic AMP formed                                                       (pmoles/mg/ in) 
Synaptosomes 53.5 
  +p-CMB (10-4M) 0 
    + + Boiled supernatant  0
               (boiled sup) 
   +D.T.E. (10-3M) 345.3 
 4 +Boiled sup 148.5 
 Boiled sup  -Synaptosomes  328.1 
 Synaptosomes +p-CMB  +Boiled sup  0 
 + +D.T.E. +Bolied sup  0 
 Boiled sup.  +  +  Synaptosomes 0 
                                 +D.T.E.  +  Synaptosomes 288.3
      The boiled supernatant obtained as described in Methods, equivalent to 304  gg of 
    protein, was added to each incubation medium. 
    * Materials indicated each column were added to the  flask  ;  A160 sec.  B: 30 sec. prior 
    to the addition of substrate  (3H-ATP). p-CMB: p-chloromercuribenzoate. D.T.E.: 
    Dithioerythritol. 
adenylate cyclase activity was profoundly stimulated by the addition of the boiled 
supernatant, however, this increased cyclic AMP formation was also gradually de-
creased by increasing the concentration of p-CMB. The differences between the 
concentrations of p-CMB required for the blockade of cyclic AMP formation in  ,-;yn-
aptosomes in the absence and in the presence of the boiled supernatant suggests that 
the boiled supernatant might have sulfhydryl groups, however, it is not clear at this 
stage whether or not the stimulatory substance(s) in the boiled supernatant does indeed 
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          Fig.  6-34 Effects  of varying concentrations of cysteine, glutathione and 
               coenzyme A on the cyclic AMP formation in synaptosomes in the
               absence and in the presence of the boiled supernatant (0.2 mgof 
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have sulfhydryl groups, since the purification of this stimulatory substance(s) is still in 
progress. 
   To examine the more precise role of sulfhydryl groups of synaptosomal adenylate 
cyclase, the order of addition of synaptosomes (enzymes), p-CMB, the boiled super-
natant and dithioerythritol, which maintains sulfhydryl groups, varied during prein-
cubation and the results are shown in Table 6-2. As can be seen, when synaptosomes 
were added to the incubation medium after the addition of dithioerythritol  (10-3M), 
the enzymic activity was not inhibited by p-CMB  (10-4M). However, once sulfhydryl 
groups of synaptosomes had been occupied by p-CMB, the enzymic activity was not 
restored by the addition of dithioerythritol. 
   As can be seen from Table 6-2, synaptosomal adenylate cyclse was sensitive to 
dithioerythritol and thus the following experiments were carried out. When sul-
fhydryl compounds such as cysteine, glutathione and coenzyme A were added to the 
assay system, all three sulfhydryl compounds increased the enzymic activity in both 
the absence and presence of the boiled supernatant as shown in Fig.  6-3. Of the three 
compounds, cysteine was the most effective. 
6-4. Effects of Adenine Nucleotides 
   The  effects of adenine, adenosine and adenosine monophosphate (AMP) on the 
synaptosomal adenylate cyclase in the absence and in the presence of the boiled su-
pernatant are shown in Fig. 6-4. Higher concentrations of AMP  (10-3M) inhibited the 
basal enzymic activity. The increased cyclic AMP formation by the boiled super-
natant was reduced by higher oncentrations of adenosine and AMP. 
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6-5. Effect  of  1,  2-bis-(2-dicarboxymetiylaininoethoxy)ethanc  (EGTA) 
   The effect of the inclusion of various concentrations of EGTA in the enzyme 
reaction mixture in the absence and in the presence of the boiled supernatant is shown 
in Fig. 6-5. As illustrated in this figure, maximal stimulatory effects were obtained 
when the concentrations of EGTA were  10-4M and 5 x  10-51VI in the absence and in the 
presence of the boiled supernatant,  respectively. 
 Adenosine  Soiled  Supernatant 
 -fp--  AMP 
 300  -  \denine 
             ^ 
200 
 D.  1 
 J. 
 10-5  10-4  10-3 
 CONCENTRATION  (m) 
 Fig. 6-4. Effects of varying concentrations of adenine nucleotides on the 
              formation of cyclic AMP in synaptosomes in the absence and in the
               presence of the boiled supernatant  (0.25  mg of protein).    , 
             Adenine.  0  , Adenosine.  AMP. 
                       400 
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          Fig. 6-5. Effect of EGTA on the formation of cyclic AMP formation in 
               synaptosomes in the absence (open symbols) and in the presence
              (closed symbols) of the boiled supernatant (0.2 mg of  protein). 
               Varying concentrations of EGTA were included in the usual incu-
               bation medium. Each value represents the mean of 3 determina-
               tions with standard derivation. 
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             Table 6-3. Effects of products of ATP breakdown on the for-
                  mation of cyclic AMP in synaptosomes 
         AdditionsCyclic AMP formed  tpmoles/mg of pr tein/min) 
   None 62.2 
         Boiled supernatant 457.1 
      ADP (10-4M) 73.6 
           Boiled  sup+  ADP (10-4M)  321.8 
      ADP  (10-3M)  26.4 
           Boiled sup+ADP  (10-3M) 180.6 
     Pi  (10-4M) 73.4 
           Boiled sup+Pi (10-4M) 309.2 
     Pi  (10-3M) 61.8 
           Boiled  sup+Pi (10-3M) 256.7 
         --- •   
              The boiled supernatant obtained as described in Methods, 
             equivalent to 304  y g of protein, was added to each incubation 
                 medium. 
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          Fig. 6-6. Effects of dopamine and serotoninon  synaptosomal  adenylate 
               cyclase in the absence and in the presence of the boiled supernatant 
 )0.25  mg  of  protein).  —0  -  Dopamine.  Histamine.  --
                  Serotonin. 
6-6. Effects of Adenosine  Diphosphate(ADP) and  Phosphoric Acid  (Pi) 
   The effects of ADP and Pi on the synaptosomal adenylate cyclase were investi-
gated. As can be seen in Table 6-3, in the absence of the boiled supernatant ADP 
 (10-4M) and Pi  (10-4M) gave a slight stimulation, ADP  (10-3M) gave an appreciable 
inhibition but Pi (10-3M) did not effect significantly to the  enzymic activity. Stimu-
lation of cyclic AMP accumulation by the boiled supernatant was gradually decreased 
by increasing the concentration of either ADP and Pi. 
6-7. Effects of  Dopamine, Histamine and Serotonin 
   The effects of neurotransmitters such as dopamine, histamine and serotonin on 
the synaptosomal adenylate cyclase are  shown in Fig. 6-6. The basal  enzymic  activ. 
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          Fig. 6-7. Effects of GTP and  carbamylcholineonthe formation of cyclic 
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              boiled supernatant (0.25 mg of protein). Each value representshe
                mean of 2 determinations onone preparation. 
ity was not affected by the addition of such neurotransmitters but the boiled super-
natant-stimulated enzymic activity was reduced by higher concentrations of dopamine 
and serotonin. 
6-8. Effect of Guanosine  Triphosphate (GTP) 
   The effects of varying concentrations of GTP on the synaptosomal adenylate 
cyclase in the absence and in the presence of the boiled supernatant were investigated 
and the results are shown in Fig. 6-7. GTP seems to have little effect on the basal and 
the boiled supernatant-stimulated cyclic AMP formation in synaptosomes as well as 
in the preparation of horse parathroid gland (Matsuzaki et al. 1972). 
6-9. Effect of  Ca•bon_vicholine 
   The effect of  carbamylcholine on the synaptosomal adenylate cyclase in the ab-
sence and in the presence of the boiled supernatant is given in Fig . 6-7. As can be 
seen,  carbamylcholine did not affect the basal and the boiled supernatant-stimulated 
cyclic AMP formation at all. 
6-10. Discussion 
   Previously, synaptosomes have been difined by Whittaker (1965) and Whittaker 
and Greengard (1971) as detached nerve endings, usually including postsynaptic mem-
branes and intersynaptic structures. During the process of isolation, these pinched off 
nerve terminals seal, thus maintaining an inner biochemical composition which closely 
resembles that of the synaptic ending in the living animal. This finding had led many 
investigators to study the in vitro mechanism of synaptosomes, in order to help un-
derstanding of the role played by synaptic structures in the dynamic processes of the 
nervous system.  One metabolic function of synaptosomes, the ability to incorporate 
amino acid into protein in vitro, has been the subject of much interest  amoung neuro-
biologists. 
   Since the original report by Morgan and Austin (1968), many papers have  op-
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peared dealing with the in vitro incorporation of radioactive precursors into macro-
molecules of  synaptosomal preparations (Gordon and Deanin  1968  ; Autilio et al. 1968  
; Morgan and Austin 1968,  1969  ; Appel et al.  1969  ; Bosmann and  Hemsworth  1970  ; 
Goldberg 1971 ; Cotman and Taylor 1971 ; Bridger et al. 1971 ; Gambetti et al. 1970  
;  Hernandez et al.  1971). In addition, studies on the axonal transport of protein (Droz 
and Barondes 1969) have provided indirect evidence for local protein synthesis in nerve 
endings. From these data, brain synaptosomes eem to be able to serve an excellent 
in vitro model for analyzing the effects of agent on these uptake mechanism. 
   From the electron microscopic observation shown in  Fig.  3-2, synaptosomes 
appear to be presynaptic nerve endings which are detached from their axons and 
 postsynaptic attachments and seal off to form small particles when the brain tissue is 
homogenized. As noted previously, these particles contain mitochondria and synaptic 
vesicles and retain many of the morphological and chemical characteristics of the 
intact synaptic terminal. These facts led us to pursure the properties of the syn-
aptosomal adenylate cyclase. 
   Recently, it has been reported that  methylmercury is a potent inhibitor of ade-
nylate cyclase in rat liver plasma membranes (Storm and Gunsalus 1974). The results 
in Fig. 6-2 showing that the synaptosomal adenylate cyclase from the rat brain cere-
bral cortex was inhibited by the sulfhydryl reagent such as p-CMB suggest that 
organomercurials may react well with protein sulfhydryl groups of synaptosomal 
plasma membranes as those of liver plasma membranes. It has been reported, how-
ever, that sulfhydryl groups were required for adenylate cyclase activity of rat liver 
plasma membranes but were not required for the stimulation of this activity by sodium 
fluoride or  ACTH (Kelly and Koritz 1971). The cyclic AMP accumulation in the 
presence of both the boiled supernatant and  10-5M p-CMB shown in Fig. 6-2 appears 
to be caused by the interaction between the remaining sulfhydryl groups of synapto-
somes which had not reacted with p-CMB and a stimulatory substance(s) in the boiled 
supernatant. Once these sulfhydryl groups of synaptosomes had been lost as a result 
of reaction with p-CMB, the enzymic activity was not restored by the addition of 
dithioerythritol as can be seen from Table 6-2. These results indicate that  sulfhydryl 
groups are required for the basal enzyme activity and for its stimulation by the boiled 
supernatant. This obserration supports the hypothesis that the sensitive sulfhydryl 
groups(s) may be associated with the catalytic subunit of adenylate cyclase. It has 
been suggested  by Storm and Dolginow (1973) that the reactivity of the sulfhydryl 
group(s) of liver plasma membranes is pronouncely stimulated by glucagon and its 
binding may promote conformational changes within the adenylate cyclase system 
resulting in either increased or enhanced nucleophilicity of the crucial sulfhydryl 
group(s). 
    Divalent cations play a crucial and to some extent not yet well understood role in 
regulation of adenylate cyclase activity. Thus Sutherland and co-workers (Suther-
land and Rall 1958,  1962  ; Rall and Sutherland  1962  Murad et al. 1962), the discover-
ers of adenylate cyclase, first pointed out that this enzyme had an absolute requirment 
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for  Mg++. 
   On the other hand, several inconclusive results concerning the effect of  Ca" on 
adenylate cyclase have been reported (Williams et al  1969  ; Taunton et al.  1969  ;
Robison et al.  1970  ; Bradham et  al.  1970  ; Bradham  1972  ; Hungen and Roberts 1973). 
The results in Fig. 6-5 show that EGTA, which is a specific chelator for  Ca", caused 
a stimulation of the enzymic activity with and without the boiled supernatant. This 
 stimulatory effect has not been adequately explained.  Ca" also inhibits adenylate 
cyclase in other  tissues  : fat, heart and adrenal tissues (Birnbaumer et al.  1969  ;
Drummond and Duncan  1970  ; Lefkowitz et al. 1970) but to a lesser extent. Bir-
nbaumer et al. (1969) suggested that calcium and magnesium compete for a putative 
allosteric site of the adenylate cyclase enzyme system in fat cell membrane. The 
data obtained in the present studies that the increase of synaptosomal adenylate 
cyclase in response to EGTA in the presence of 3.3  m11,1  Mg", at which concentration 
the enzyme is approaching saturation with regard to  Mg" suggest that in this tissue 
 Ca'  + is exerting its effect by competing  Mg' for occupancy of an allosteric site. It 
therefore seems certain that  Ca" plays a significant role in controlling the adenylate 
cyclase activity in synaptosomes. 
   Although the inhibitory effect of adenosine on adenylate cyclase of rat liver has 
previously been reported  (Moriwaki and Foa 1970), such an effect of adenosine on 
synaptosomal adenylate cyclase was not observed in the present studies  (Fig.  6-4). 
The inhibitory effects were seen by the addition of adenine nucleotide (AMP, ADP) at 
higher concentrations, however, these actions do not seem to be physiological. 
   Recently, Harwood and Rodbel (1973) have reported that the loss of hormone 
sensitivity in the preparation of fat cell ghost is probably due to fluoride ion. In the 
present studies, since synaptosomal adenylate cyclase activity was not detected in the 
absence of fluoride as seen in  Fig.  6-1, sodium fluoride was customary added to the 
incubation medium. Under these conditions, as seen from Table 6-1 and Fig. 6-6, no 
stimulatory effect by catecholamines such as norepinephrine, dopamine and serotonin 
was observed in the absence and in the presence of either the native supernatant or 
boiled supernatant. These results suggest that the process of cell disruption may 
cause a dissociation of the functional relationship between the receptor and the cata-
lytic composition of brain adenylate cyclase. 
   Purine nucleotide triphosphates have been shown to be necessary for the expres-
sion of hormone stimulation, not only in the glucagon-sensitive system from liver 
parechymal cell (Birnbaumer et al. 1972), but also in the glucagon-sensitive system 
from pancreatic cell (Golfine and Birnbaumer 1972), and in  prostaglandin-sensitive 
system from human plateletes (Krishna et al. 1972).  It is, therefore, of prime impor-
tance to test the hypothesis the purine nucleotide-dependent step (notable GTP de-
pendent) might be an invariant feature of the hormone-sensitive adenylate cyclase 
 system, possibly acting at the step that couples hormone-receptor interaction to 
enzyme activation. The effects of varying concentrations of GTP on synaptosomal 
adenyate cyclase in the absence and presence of the boiled supernatant were  investi-
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 Fig_ 6-8  Hypothetical scheme of the relationship between the increase of 
               cyclic AMP  formation,  Ca—, sodium fluoride and  cysteine in  syn-
                   aptosomes. 
gated in order to examine the interaction of GTP and the  stimulatory substance(s) in 
the boiled supernatant (Fig. 6-7). As can  be seen, GTP did not significantly affect the 
enzymic activity in either the absence or presence of the boiled  supernatant , suggest-
ing that there is no interaction between the two . These results are at variance with 
those previously reported concerning GTP or  Gp,(NH), activation of basal adenylate 
cyclase preparations from rat liver or fat plasma membranes (Rodbell et al . 1971  ;
Londos et al. 1974) and mouse neuroblastoma  x  glioma hybrid cell (Sharma et al. 1975). 
Such a variance may be due to the different assay conditions of the incubation system 
or to the different enzyme preparations. 
   It has been previously reported that synaptosomal plasma membrane differs from 
most other plasma membranes as described below.  Erythrocyte ghost (Dodge and 
Phillips 1967), and plasma membranes from plateletes (Marcus et al . 1969), liver 
(Pfleger et al.  1965  ; Dod and Gray  1968  ; Ray et al. 1969) and L-cells (Weistein et al. 
1968) all have higher cholesterol/phospholipid molar ratios and contain much greater 
amounts of  sphingomyeline. In general, other plasma membranes seem to be char-
acterized by a low content of glycolipids, but in the case of the synaptosomal plasma 
membranes, there are high levels of gangliosides and triphosphoinositide (Lapetina et 
al.  1967  ; Breckenridge et al.  1972  ; Hayashi 1975). Accordingly , in view of the pres-
ent results and the following results by other investigators shown below , the following 
tentative model for the system which regulates cyclic AMP levels in  synaptosomes is 
proposed as shown in Fig. 6-8. The following results have earlier been  reported  : (1) 
Both cysteine and sodium fluoride inhibit diphosphoinositide (DPI) kinase activity (Kay 
1968) and stimulate cyclic AMP formation in synaptosomes (in this thesis) . (2)  Ca" 
inhibit  adenylate cyclase activity or EGTA stimulate adenylate cyclase activity 
(Hungen and Roberts  1973  ; Izumi and Ozawa 1975). (3) Triphosphoinositide (TPI) 
binds with  Ca+* (Dawson 1965). (4) Cyclic AMP activates the binding of  Ca÷- with 
plasma membrane (Shatz 1972). (5) A number of amounts of TPI and DPI exists in 
the brain (Dawson and  Diffmer 1961). (6)  Ca' in excitable membrane has a physio-
logically important  function  : the ion-permerable resting state is maintained by the 
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binding of  Ca' on it, by the liberation of  Ca+ the polarity of the membrane compo-
nent changes and becomes ion-permeable, and this process could be the initial step in 
excitaion (Tasaki 1968). (7) The dissociating effect of  acetylcholime on  TPI-  pro-
tein-Ca— may be  involvled in excitation process of the synaptic membrane (Hayashi 
and Katagiri 1974). If this postulation is true, it seems reasonable that the increase of 
cyclic AMP formation by cysteine and sodium fluoride are mediated via their effects 
on DPI kinase. On the other hand, EGTA decreases the membrane bound  Ca+- levels, 
and then produces the increase of cyclic AMP accumulation. However, it remains 
unknown where the stimulatory substance(s) in the supernatant acts. 
CHAPTER 7 STIMULATION OF SYNAPTOSOMAL  CYCLIC AMP PHOSPHODIESTERASE BY 
          THE BOILED SUPERNATANT 
 7-1. Separation  of  the Stimulatory Substance(s) on  Sephadex  G-25  Supedine 
   As previosuly mentioned in chapter 3, the supernatant contained the soluble  stim-
         E 
            2 al      E 
                                                a' 
                       0200- . 50 'in2.0                                        a•
          a E 
           E 
             •13150-                       -0 
 1,1  >.  5                                            •cz)         ^EO co 
     D100-2545  -10("4 
    u•  1:1 
                     u                        _c 111--/• 
  a_El_ 12_  t                          • C  2 2
50 0          <1" 
 8• 
 7.5                      >,  U
.(-)<   •. 
        10 20 30 
 Fraction number 
         Fig. 7 1. Chromatography of the 105, 000  x g supernatant from  rat cere-
               bral cortex on Sephadex G-25 superfine. Rat brain cerebral cortex
 was homogenized in five volumes of ice-cold 10  mill Tris  11C1 buffer 
              (pH 7.4). The homogenates was centrifuged  ;  1,000  , g for 20min. 
              10,000  x g for 20  min and 105,000 x g for 60  min. The resulting su-
              pernatant was lyophilized and then applied to a column of Sephadex 
              G-25 superfine (1.5 x 43 cm) equilibrated previously in 50  mMTris-
              1-1C1 buffer  (pH  7.4). The column  was  elued with same buffer in 2.5 
              ml fractions at a flow rate of  10  ml per hour. An  aliquot  (100  k  1) of
              each fraction was assayed for its cyclic AMP phosphodiesterase
              activity  (—C—) and its ability to activate the synaptosomal ade-
              nylate cyclase (—e--- ) or synaptosomal cyclic AMP phosphodies-
               terase activities  (—M-1. The protein content of synaptosomes was 
 200  g in each asch assay. Column buffer alone has  no effects on 
              adenylate cyclase and cyclic AMP Phosphodiesterase activities. 
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ulatory substance(s) which increased the accumulation of cyclic AMP in synaptosomes 
from rat brain cerebral cortex. The finding prompted us to determine whether or not 
this accumulation of cyclic AMP resulted from an inhibition of cyclic AMP phospho-
diesterase in synaptosomes. Accordingly, the effects of the boiled supernatant on this 
enzyme have been investigated. As described earlier in chapter 5, synaptosomal cyclic 
AMP phosphodiesterase was also activated by the boiled supernatant. Hence the 
following experiments were carried out. As can be seen in Fig. 7-1, when aliquots 
(100  gl) of the Sephadex G-25 column fraction were examined for the ability to acti-
vate the synaptosomal cyclic AMP phosphodiesterase as well as in case of the 
 adenylate cyclase shown in Fig. 4-2, the coincident peaks of acitivating substance(s) 
were found (fraction 23) for two enzyme activities. The activity of first peak fraction 
(fraction 12-14) is likely to be originated from cyclic AMP phosphodiesterase con-
tained in the supernatant, because this corresponding activity was not observed when 
the boiled supernatant was fractionated. 
7-2. Effects of Sodium Fluoride on  Adenylate  Cyclase and  Cyclic AMP Phosphodiesterase 
   In order to examine the relation of the stimulatory effects between adenylate 
cyclase and cyclic AMP phosphodiesterase, sodium fluoride, a potent activator of 
adenylate cyclase in tissue homogenates (Birnbaumer et al.  1969  ; Perkins and Moore 
 1971  ; Drummond et  al. 1971), was added to each incubation medium, and then both 
enzyme activities were assayed. As shown in Fig. 7-2, it was found that a plot of 
adenylate cyclase activity to sodium fluoride concentration in synaptosomes was 
sigmoidal in nature in accordance with the observations of Birnbaumer et al. (1969) for 
rat fat cell ghost and of Perkins and Moore (1971) for rat cerebral cortex homoge-
nates. However, the addition of varying concentrations of sodium fluoride to a cyclic 
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           Fig. 7-2. Effect of concentration of sodium fluoride (NaF) on adenylate 
 ) and cyclic AMP phosphodiesterase activities  (---C—) in 
                 synaptosomes from rat cerebral cortex. The protein content of
                 synaptosomes was 200  ,u  g in each assay. 
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          Table  7-1. Effect of the  stimulatory factor(s) on soluble supernatant and 
 synaptosomal cyclic AMP phosphodiesterase ctivity 
   Enzyme  With                                      Control 
       preparations stimulatory factor(s) 
         Supernatant  42.8 ±  5  .  1  39.8 ± 4  .  0
 Synaptosomes 46.6 ± 5.1 84.1  ± 7.0* 
            Rat cerebral cortex was homogenized in 50 mM  Tris-HCI buffer(pH7.4). 
          The homogenate was centrifuged at 1,000 x g for 20  min, 10,000 x g for 20
 min and  105,000 x g for 60  min. The 105,000 x g supernatant was dialyzed 
          extensively againist he same buffer. An aliquot of this supernatantfluid 
          was used as a source of cyclic AMP phosphodiesteaset The  synaptosomes 
          were prepared as described in the Methods. One-tenth ml of thestimula-
          tory fraction (23 fraction) from a Sephadex G-25 superfine shown in  Fig. 
 7.1 was added to the enzyme system as the stimulatory factor. Protein 
          concentrations i  p  g per 0.5 ml of the reaction mixture  : supernatant,30  ; 
 synaptosomes, 220. Activity is expressed as  mu moles of cyclic AMP 
          hydrolyzed per 15  min. The values hown are the average results of single 
          experiment carried out in triplicate. The ranges of values are represented 
           by average deviations. 
             * The additionof the stimulatory factor significantly increased cy-
               clic AMP phosphodiesterase ctivity of the synaptosomes  (p<  0.01).
            Table 7-2. Effects of various concentrations of imidazole on solu-
                 ble supernatant and synaptosomal cyclic AMP phosphodies-
                  terase activity 
 Addition Supernatant Synaptosomes 
           Imidazole (mM) 
    0  35.3 54.9 
    5  40.6 52.8 
    10 41.5 55.1 
    20  51.7 77.1 
    40 54.9  82.4 
    80  44.6  73.7 
              The enzyme preparations of the supernatant and thesynapto-
            somes were prepared as described in Table  7-1 and Methods,re-
            spectively. Protein concentrations in pg per 0.5 ml of the reaction
 mixture  : supernatant,  30  ; synaptosomes 220. Activity is express-
            ed as  my moles of cyclic AMP hydrolyzed per 15  min. Thesolution 
            of imidazole was adjusted to pH  7.4 with acetic acid. 
AMP phosphodiesterase assay system did not affect the enzymic activity at all, sug-
gesting that there is no relationship between the stimulation of adenylate cyclase and 
that of cyclic AMP phosphodiesterase. 
7-3. Effect of  Imidazole 
   It has been reported that the brain cyclic AMP phosphodiesterase is distributed in 
both soluble and particulate fractions (Robertis et al.  1967  ; Cheung and Salganicoff 
1967). Although the relationship between these two enzymes is not fully understood, 
a comparative study of the effects of the stimulatory substance(s) in the supernatant 
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and imidazole on cyclic AMP phosphodiesterase in the both soluble and  synaptosomal 
enzymes was carried out. As can be seen from Table  7-1. in contrast to membrane 
 bound cyclic AMP phosphodiesterase, the enzyme in the soluble supernatant was not 
stimulated by the addition of the  stimulatory fraction.  However, the addition of 
imidazole, an activator for cyclic AMP phosphodiesterase (Butcher and Sutherland 
1962), stimulated the enzyme activity in both soluble and  synaptosomal enzymes 
(Table  7-2). These results indicate that the mode of action of this stimulatory sub-
stance(s) on the synaptosomal cyclic AMP phosphodiesterase is different in some 
manner from that of imidazole. These results also suggest that this stimulatory 
substance(s) would he different from those obtained by various investigators (Kakiuchi 
and Yamazaki  1970  ; Cheung  1970,1971 ; Teo et al.  1973) in molecular weight and the 
specificity on the membrane-bound cyclic AMP phosphodiesterase. However, it 
cannot be concluded at this stage whether the stimulatory substance(s) of adenylate 
cyclase and cyclic AMP phosphodiesterase are the same or not. 
CHAPTER 8. CONCLUSION  DISCUSSION 
   There is evidence for a cellular localization of the catecholamines such as nor-
epinephrine, dopamine and 5-hydroxytryptamine within specific neuron systems of the 
brains of laboratory animals (Carlsson et al. 1962 ;  Falck et al. 1962). The distribu-
tion of the bodies and terminals of monoamine nerve cells is known in detail for the 
rat, and the presence of these cells had been documented also in other species  (Dals-
trom and Fuxe 1964). Figure  8-1 shows that the cerebral cortex of the rat contains a 
number of the nervous cells. Considerable amounts of catecholamines have been 
shown to present in the rat brain (Karki et al.  1962 ; Pletscher et al.  1963  ; Barchs and 
Freedman  1963  ; Hansson et al.  1964  ; Baird and Lewis 1964). However, the func-
tional significance of the various monoamine neuron system, for instance their in-
volvement in the mechanism of action of psychotropic drugs, is under study. 
   Brain tissue contains extremly high levels of adenylate  cyclase, phosphodiesterase 
and protein kinase. The level varys in different brain  regions  ; it is particulary high 
in grey matter and low in white matter. In homogenates of brain tissue, high levels of 
adenylate cyclase, phosphodiesterase. protein kinase and phosphoprotein phosphatase 
have been found in particulate fractions generally referred to as  "synaptosomes" 
(Robertis et al.  1967  ; Weiss and Costa  1968  ; Maeno et al. 1971 ; Maeno and Green-
gard 1972). As shown in Fig. 3-2, these consist of piched-off nerve-endings in the 
form of resealed entities containing mitochondria and transmitter storage vesicles, 
along with an adhering  postsynaptic membrane. Thus, all the components of the 
cyclic AMP system are present as part of the synaptic complex. 
   However, as noted previously, the adenylate cyclase in homogenates of brain 
tissue hardly retains the receptor-mediated regulation of activity which is always seen 
in cell-free preparations from other tissues. Thus, although biogenic amines, ade-
nosine and prostaglandin elicit significant accumulations of cyclic AMP in intact cells 
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           Fig.  8-1. Electron micrograph from rat cerebral cortex.  m myelinated 
               axon,  a  :  unmyelinated  axon;  v  : synaptic  vesicle  ; s: thickened 
                 apposed membrane ofpost-synaptic  processes.  - 25.000. 
of brain slices, they have either no effect or only small effects on the activity of 
adenylate cyclase in homogenates of brain tissues (Sattin and Rall  1970  ; Klainer et al. 
 1962 William et al.  1969  ; Rall and Sattin  1970  ; McCune et  al.  1971  ; Drummond et 
al. 1971). The magnitude of the small effects of such agents on adenylate cyclase 
in homogenates is dependent upon the methods of homogenization and assay, probably 
due to the lack of direct relationship of results obtained by different groups of inves-
tigators. In view of the present problems in retaining hormonal responsiveness of 
adenylate cyclase in homogenates, it would appear. premature to attempt to difine the 
loci of hormone responsive systems present in the intact tissue by classical fractiona-
tion techniques. 
   More recently, homogenization and fractionation techniques which afforded a 
cell-free particulate preparation from brain tissue that retains a hormone-responsive 
cyclic AMP-generating system have been reported by  Chasin et  al. (1974). Particu-
larly, they used a  3Ii-adenine prelabelling technique and prepared a homogenates 
from cerebellum, cerebral cortex and hyppocampus in Krebs-Ringer  buffer. This 
method enabled them to formulate a model of a cell-free, vesicular, hormonally re-
sponsive adenylate cyclase preparation from brain. However, in the present studies, 
the effects of the supernatant on adenylate cyclase cyclase in  synaptosomal prepara-
tion have not been investigated using this method. 
   On the other hand, an increasing amount of evidence suggests that cyclic AMP 
may be involved in the regulation of metabolism and function in nervous tissuls 
(Greengard and Costa 1970). Certain data suggest that cyclic AMP may be intimately 
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associated with the molecular events underlying the process of synaptic transmission. 
For  instance. evidence has been presented that exogenous cyclic AMP can mimic the 
 inhibitory effect of norepinephrine on  cerebellar Purkinje cells (Siggins et  al. 1971). 
Moreover, synaptic activity in autonomic ganglia caused a several-fold increase in the 
amount of cyclic AMP in the ganglia in brief periods, which occurred largely, if not 
entirely, in postsynaptic cells (McAfee et  al. 1970). Greengard et al. have previously 
suggested that this increase in cyclic AMP may modify the excitability of certain 
postsynaptic cells by the following chain of event (McAfee et  al.  1970  ; Greengard and 
Kuo 1970) :(i) activation of a protein kinase by cyclic AMP, (ii) phosphorylation of the 
synaptic membrane by the kinase, (iii) change of ionic permeability of the membrane, 
(iv) change of membrane potential, and (v) change of excitability. Although this 
scheme provides a plausible molecular mechanism for prolong modulation of synaptic 
transmission either by facilitation or by inhibition, there are several objections to met 
before such a hypothesis can be adopted. For example, contrary to the above hy-
pothesis, it has also been postulated by Rasmussen and Tenenhouse (1968) that as 
cyclic AMP is a weaker calcium ion chelating agent than is adenosine triphosphate 
(ATP), the conversion of membrane bound ATP to cyclic AMP releases  Ca" which is 
complexing with other membrane constituents such as phospholipids. And, as results, 
the membrane becomes permeable to  Ca'. The involvement of  Ca" in process such 
as catecholamine release and muscle contraction is well  known  ; so it seems that 
simply the conversion of ATP to cyclic AMP may have important physiological con-
sequences. 
   As shown in this thesis, the supernatant from rat cerebral cortex contains a 
stimuiatory substance(s) which increases the accumulation of cyclic AMP in syn-
aptosomes. However, at this stage a reasonable explanation for the physiological 
significance of this substance(s) cannot be offered. 
   The presence of low molecular factors concerning the regulatory factors such as 
an inhibitory factor of brain ATPase (Schaefer et al. 1972, 1973, 1974,  1975  ; Izumi et 
al. 1976a), endogenous inhibitors of  dopamine-/3-hydroxylase (Duch and Kirshner 1971  
; Izumi et  al.  1975c  ; Oyama et al. 1975a, 1976). a relaxing factor of smooth muscle 
(Florey  1953  ; Florey and Mclennan  1955  ; Suzuki et al. 1971), a collagen stimulatory 
factor (McGee et al. 1973) has earlier been reported. However, the both characteri-
zation and purification of these factors have not yet been completed, and their phys-
iological functions are still the subject of controversy. 
   In view of the similar properties (heat-stable, dialyzable and probably sulfhydryl 
compounds) amoung the factors of adenylate cyclase (Izumi and Ozawa 1975), of 
 dopamine-,3-hydroxylase (Izumi et  al. 1975b) and of ATPase (Izumi et al. 1976a), it is 
possible to speculate that these factors may be identical. However, it seems to be 
premature to draw a definite conclusion, because these have not yet been purified 
completely. On the other hand, since both enzymes, adenylate cyclase and ATPase, 
are membrane bound enzymes and since isolated plasma membranes contain other 
enzymes such as myokinase, ATP pyrophosphohydrolase and 5'-nucleotidase, it seems 
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to be  difficult to establish the definite sites of  actions of these factors on each enzyme. 
Because of these reasons, and because the preparation of  dopamine-i3-bydroxylase 
coulde be highly purified, the properties and the site of action of the naturally occur-
ring inhibitors of  dopamine-i3-hydroxylase (Izumi et al.  1975b,  Oyama et  al. 1975a, 
1976) were investigated and the inhibition of  dopamine-)3-hydroxylase by various 
agents (Izumi et al.  1976b, c, d,  f  ; Oyama et al.  1975b) were further investigated. 
CHAPTER 9. MATERIALS AND METHODS 
9-1. Materials 
 [3  H  ]ATP (uniformly labeled) was obtained from New England Nuclear Corp. 
 [8-14C]cyclic AMP was purchased from Schwarz Bioresearch. Crystalline adeno-
sine  5'-triphosphate disodium salt (ATP), tris(hydroxymethyl)aminomethane d 
DL-norepinephrine were obtained from Sigma Chemical Co. Cyclic AMP was pur-
chased from Daiichi Pure Chemical Co. Sodium  fluride was obtained from Kanto 
Chemical Co. GTP was obtained from Kyowa Co. Ltd. Adenine and adenosine were 
obtained from Kohjin Co. Ltd. p-Chloromercuribenzoic a id sodium salt  was pur-
chased from Nakarai Chemical Ltd. All other chemicals were reagent grade prepa-
rations obtained from various commercial sources. 
9-2. preparation of Subcellular Fraction 
   Sprague-Dawley male rats (CLEA Japan, Inc.), weighing 250-300 g, were used in 
the experiments. After animals were decapitated, brains were isolated and chilled in 
the ice-cold solution containing 0.32 M sucrose and  3.0  mM  MgSO4. Subsequently, 
the cerebral cortexs were isolated of Glowinski and Iversen (1966) and were homoge-
nated in 9 volumes of the same isotonic cold solution using a glass homogenizer with 
a loose Teflon pestle. The homogenates  were centrifuged at  4°C for 20  min at 1,000 
g. The supernatant fluid  (1,000  x  g supernatant) was pooled and centrifuged at 
10,000 x g for 20  min at  4°C. The precipitate was diluted with the same sucrose me-
dium and designated as the crude mitochondrial fraction (10,000 x g sediment). The 
supernatant was centrifuged at 105,000 x g for 60  min at  4°C. The precipitate was 
designated as the microsomal fraction (105,000 x g sediment) and the supernatant 
fraction as the supernatant (105,000  x g supernatant). The 105,000  x g supernatant was 
heated in a boiling water bath for 5  min and then, after 10-20  min at  O`C, centrifuged 
at 10,000 x g for 10  min at  4°C. This supernatant was used as the boiled supernatant. 
9-3. Assay of Cyclic AMP Phosphodiesterase 
   Cyclic AMP phosphodiesterase was assayed by the method of  Poch (1971) using 
cyclic AMP as the substrate at the concentration of 3.6 x  10-4 M. The enzymic ac-
tivity was measured as the rate of hydrolyzing cyclic AMP in a standard reaction 
medium (final volume 500  pl) containing  8-1dC-cyclic AMP (0.05  pCi),  3.0  mM  Mg-
acetate, 2.0 mM 5'-AMP, 100 mM  Tris-HCI buffer (pH 7.4) and the enzymes. Incuba-
tions were run at  30°C for 15  min. The reaction was stopped by adding 200  ,u1 of 0.17 
M  ZnSO4 and 200  pl of 0.15 M Ba(OH)2. After centrifugation (2,500 rpm, 10  min), 300 
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p 1 of the supernatant was transferred into a counting vial with 10 ml of scintillation 
medium (4 g of PPO, 100 mg of dimethyl POPOP, 100 ml of toluene, 400 ml of 99.5% 
ethanol and 100 ml of dioxane). The radioactivity was then determined by a liquid 
scintillation spectrometer (Packard  Tri-Car Model 3380). 
9-4. Assay of ATPase 
   Reaction mixtures (1.0 ml) contained  5.0  mM MgC12, 14 mM  KC1, 140 mM  NaCI, 50 
mM  Tris-HCI buffer (pH 7.4) and tissue suspension. The mixtures were shaken at 
 30°C for 5  min and the reaction was initiated by the addition of Tris-ATP (0.1 ml) to 
give a final concentration of 3.0 mM. Shaking was continued for a further 15  min, and 
2.0 ml of 10%  (NV  /V)  trichloroacetic acid solution then added. Protein precipitate was 
spun down, and inorganic phosphate in samples was measured from the supernatant by 
the method of Fiske and Subbarow (1925). 
 9-5. Electric Microscopic Observation 
   Adult male rats (Sprague-Dawley, CLEA Japan, Inc.) weighing  300-350 g were 
used. After decapitation, the brain was quickly removed, and then the cerebral cor-
tex was isolated by the method of Glovinski and Iversen (1966). The specimens were 
cut into small pieces. Synaptosomes were prepared by the method of Whittaker 
(1959) as shown in chapter 3. 
   Fixation was carried out for about two hours in  1% ice-cold osmium tetroxide. 
This fixatives were adjust to pH 7.4 with Millonig's phosphate buffer (Millonig 1962). 
They were then dehydrated in ethanol and transferred into propylene oxide, and 
embedded in Epon 812 (Luft 1961). Thin sections were stained with  1% uranyl acetate 
for ten minutes followed by Millonig's lead stain (Millonig 1961). A JEM-T7  elec-
tron microscope was used for observation. 
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